Related Experiment Video

Updated: Oct 23, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
11:08

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

Cancer carve outs, specialty networks, and disease management: a review of their evolution, effectiveness, and

B Kurowski1

  • 1Kurowski and Company, Inc., Los Angeles, CA 90025, USA. bkurowski2@aol.com

The American Journal of Managed Care
|May 31, 1998
PubMed

Insights

Cancer care programs, including carve-outs and disease management, face slow growth and limited success due to financial and operational hurdles. Further research and policy changes are needed to improve their performance and market influence.

Area of Science:

  • Health Services Research
  • Oncology
  • Healthcare Management

Background:

  • Specialty care programs for cancer patients were early innovations but exhibit slow growth and limited success.
  • Existing cancer carve-outs, disease management programs, and specialty networks face significant challenges.

Purpose of the Study:

  • To review the evolution of cancer care programs.
  • To identify financing and operational impediments to program growth.
  • To analyze critical factors hindering development and suggest improvements.

Main Methods:

  • Distinguishing purchasers from sellers in cancer carve-outs, disease management, and specialty networks.
  • Reviewing limited published data on program success.
  • Analyzing impediments to growth and development.

Main Results:

  • Cancer specialty programs have been slow to grow and demonstrate success.
  • Financing and operational factors significantly impede program development.
  • Published data on program success is scarce.

Conclusions:

  • Critical factors impeding cancer program development require analysis.
  • Public policy changes and health services research are essential.
  • Optimizing performance and market influence necessitates further investigation and reform.

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...